Introduction
============

Asthma is one of the most common chronic respiratory diseases, affecting about 300 millions of children and adults worldwide\[[@B1]\]. In China, more than 25 millions people are asthmatic patients, which includes almost 10 million children\[[@B2]\]. Compared with the western world, the preventive controls and treatments for asthma were not well established in China \[[@B3]\]. Only a few percent of asthma patients received proper treatment. Poverty and inadequate resources are the main hindrance to reduce the burden of disease in China especially in numerous of Chinese villagers. Therefore, the best approach to reduce asthma is primary prevention through modifying the risk factors of asthma.

It is well accepted that asthma is a complex disease and both genetic and environmental factors contribute to its inception and evolution\[[@B4],[@B5]\]. Many studies regarding associations between genetic variants and asthma risk have been published and many genes were proposed as asthma susceptible genes\[[@B6]-[@B9]\]. However, the conclusions obtained from different populations were often different or even controversial. Possible roles may be that different genetic backgrounds and environment exposures in different ethnic population that may affect the pathogenesis of asthma. Thus, asthma susceptible genes in different population may not be the same.

In recent years, host genetic susceptibility to asthma has been a research focus in scientific community in China. Many genes were suggested as asthma risk factors for Chinese population; however, many of the studies drew incompatible or even contradictory results. Considering a small number of sample size may be lack of power to reveal the reliable conclusion, we carried out a meta-analysis to assess the susceptible genes for asthma in Chinese population. To our knowledge, this is the first comprehensive and largest genetic meta-analysis conducted in people of Chinese descent for any respiratory diseases.

Materials and methods
=====================

Literature search
-----------------

We conducted a literature search by using the electronic database Medline (Ovid), Pubmed, Embase, ScienceDirect, Springer, CNKI, Wanfang database, Weipu database and CBM database to identify articles that evaluated the association between genetic variants and the risk of asthma in Chinese population (Last search was updated on May 13, 2010). The search terms were used as follows: \'*asthma*or *asthmatic*\', in combination with \'*polymorphism*or *variant*or *mutation*\' and \'*Chinese*or *China*\' for Medline (Ovid), Pubmed, Embase, ScienceDirect, Springer database; \'*asthma*or *asthmatic*\', in combination with \'*polymorphism*or *variant*or *mutation*\' for CNKI database, Wanfang database, Weipu database and CBM database. All languages were included. The following criteria were used for selecting literatures in the meta-analysis: (1) the study should evaluate the association between genetic variants and risk of asthma in Chinese population from either mainland, overseas or both, (2) the study should be a case-control design published in a journal (3) genotype distributions in both cases and controls were available for estimating an odds ratio with 95% confidence interval (CI) and *P*value, (4)genotype distributions of control population must be consistent with Hardy-Weinberg equilibrium(HWE), *P*\> 0.05 (5) the polymorphism for data synthesis should be studied in at least three case-control studies, (6) polymorphisms for data synthesis should be characterized as -A/B, with the following genotypes: AA, AB and BB. Accordingly, the following exclusion criteria were used: (1) abstracts and reviews, (2)genotype frequency not reported, (3) repeated or overlapping publications (4) polymorphisms with data less than three case-control studies (5) genotype distributions of control population not consistent with HWE, (6)genetic variants not characterized as -A/B. For duplication or overlapping publications, the studies with larger number of cases and controls or been published latest were included.

Data extraction
---------------

Two independent authors (Xiaobo Li and Yonggang Zhang) checked all potentially relevant studies and reached a consensus on all items. In case of disagreement, a third author(Jie Zhang) would assess these articles. The following data were collected from each study: first author, year of publication, location of the people, ages, genotype frequencies in cases and controls.

Statistical Analysis
--------------------

For each case-control study, we first examined whether the genotype distribution in control group was according to Hardy-Weinberg equilibrium by Pearson\'s *X^2^*test <http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl>.

Any polymorphism that had been studied in at least three case-control studies was included in the meta-analysis. The strength of the associations between asthma risk and genetic variants were estimated by ORs and 95% CIs. The statistical significance of summary ORs were assessed by Z-test. The evaluated genetic models for each study were based mostly on those used in primary studies. Heterogeneity was evaluated by a *X^2^*-based *Q*statistic and was considered statistical significant at *P*value \< 0.10. *I^2^*was used to measure the percentage of variability in point estimated that due to heterogeneity rather than sampling error. When the *P*-value is \> 0.10, the pooled OR was calculated by the fixed-effects model, otherwise, a random-effects model was used. To evaluate the age-specific effects, subgroup analyses were performed by age for polymorphisms which were investigated in a sufficient number of studies(data were available from at least three case-control studies for at least one subgroup). Publication bias was examined by using the funnel plots, Begg\'s test and Egger\'s test\[[@B4]\]. The funnel plot is asymmetrical when there is evidence of publication bias. All statistical tests were performed by using REVMAN 4.2 software and STATA 10.0.

Results
=======

Candidate asthma-genes in Chinese Population
--------------------------------------------

The selection process is shown in Figure [1](#F1){ref-type="fig"}. Briefly, 2489 search results were identified from Medline (Ovid), Pubmed, Embase, ScienceDirect, Springer, CNKI database, Wanfang database, Weipu database and CBM database in the initial search. After reading the titles and abstracts, 2159 articles were excluded for abstracts, reviews, duplicated search results or not being relevant to genetic variants and asthma risk in Chinese population. By reading through the full texts of the remaining 330 articles, 7 articles were excluded for not being relevant to polymorphisms and asthma risk. The remaining 323 articles were used for data extraction. A total of 539 case-control studies were extracted from 248 articles, and 75 articles were excluded because of the absence of the usable data or not a case-control design. In meta-analysis, a small number of studies weaken the conclusions; therefore, only polymorphisms which had been investigated in at least three case-control studies were included for data synthesis. Thus, we excluded all these polymorphisms which were studied in less than three case-control studies(a total of 260 case-control studies were excluded). Hence, a total of 279 case-control studies were left. In addition, genotype frequencies for control population in 53 case-control studies were not consistent with HWE and these case-control studies were all excluded. In the remaining 226 case-control studies, data in 45 case-control studies were overlapped or duplicated with other studies and these case-control studies were all excluded. Thus, 181 case-control studies were left. Among the 181 case-control studies, some polymorphisms were studied in less than three case-control studies, and these polymorphisms were also excluded(a total of 62 case-control studies were excluded). Finally, a total of 18 polymorphisms in 13 genes in 119 case-control studies concerning genetic variants and asthma risk in Chinese population met the inclusion criteria, were identified for data synthesis (Table [1](#T1){ref-type="table"}). The characteristics of each polymorphism are listed in Table [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}, [6](#T6){ref-type="table"}, [7](#T7){ref-type="table"}, [8](#T8){ref-type="table"}, [9](#T9){ref-type="table"}, [10](#T10){ref-type="table"}, [11](#T11){ref-type="table"}, [12](#T12){ref-type="table"}, [13](#T13){ref-type="table"}, [14](#T14){ref-type="table"}, [15](#T15){ref-type="table"}, [16](#T16){ref-type="table"}, [17](#T17){ref-type="table"}, [18](#T18){ref-type="table"} and [19](#T19){ref-type="table"}. The genetic models for pooling data are also listed in Table [1](#T1){ref-type="table"}.

![**Flow diagram of included/excluded studies**.](1465-9921-11-129-1){#F1}

###### 

Genes identified from individual studies

  Gene     Chromosome location of gene   Polymorphism   Aminoacid change   Genetic model   Genotypes Evaluated   Other genotypes   Cases   Controls
  -------- ----------------------------- -------------- ------------------ --------------- --------------------- ----------------- ------- ----------
  β2-AR    5q31-32                       -46G/A         Arg16Gly           Recessive       GG                    GA+AA             1796    1589
                                         -79G/C         Gln27Glu           Recessive       GG                    GC+CC             823     692
  IL-4R    16p11.2-12.1                  -1902G/A       Q576R              Dominant        GG+GA                 AA                2308    1971
                                         -223G/A        Ile/Val            Recessive       GG                    GA+AA             1623    1304
  IL-4     5q31                          -589C/T                           Dominant        CC+CT                 TT                1724    1656
  TNF-α    6p21.1-21.3                   -308A/G                           Dominant        AA+AG                 GG                1428    1511
  FcεRIβ   11q13                         -6843G/A       Glu237Gly          Dominant        GG+GA                 AA                1434    1276
                                         -109C/T                           Recessive       CC                    CT+TT             428     371
  ACE      17q23                         D/I                               Recessive       DD                    DI+II             385     335
  IL-13    5q31                          -2044A/G       Gln130Arg          Dominant        AA+AG                 GG                1512    1351
                                         -1923C/T                          Recessive       TT                    CC+CT             645     588
  IL-1β    2q12-21                       -511C/T                           Dominant        TT+TC                 CC                333     255
  LT-α     6q21.3                        +252A/G                           Dominant        GG+GA                 AA                674     896
  TGF-β1   19q13                         -509C/T                           Dominant        TT+TC                 CC                406     390
  CD14     5q31.1                        -159C/T                           Dominant        TT+TC                 CC                1381    1219
  ADAM33   20p13                         T1             Met764Thr          Recessive       CC                    TT+TC             569     512
  RANTES   17q11.2-12                    -28G/C                            Dominant        GG+GC                 CC                314     229
                                         -403A/G                           Dominant        AA+AG                 GG                343     205

###### 

Main data of all studies included in the meta-analysis for the -46G/A (Arg16Gly) polymorphism in β2-AR gene

                                                              Case   Control                                
  -------------------------- ----------- ------ ------------- ------ --------- ---- ----- ----- ---- ------ -----------
  Chan, I H\[[@B16]\]        Hong Kong   2008   10.4 ± 3.7    101    135       59   51    89    33   1.06   0.66-1.70
  Cui, LY(Han)\[[@B17]\]     Neimenggu   2007   21-62         6      34        2    6     20    4    0.33   0.06-1.90
  Cui, LY(Meng)\[[@B17]\]    Neimenggu   2007   26-69         3      21        6    6     19    5    1.25   0.34-4.64
  Gao, J M\[[@B18]\]         Beijing     2004   38.7 ± 13.8   38     59        28   35    53    8    3.18   1.37-7.33
  Li, H\[[@B19]\]            Shanghai    2009   3-12          86     76        30   46    100   46   0.59   0.35-0.98
  Liao, W\[[@B20]\]          Chongqing   2001   5.8 ± 4.3     12     27        11   14    28    8    1.48   0.54-4.06
  Qiu, Y Y(2008)\[[@B21]\]   Jiangsu     2008   63.2 ± 5.6    25     31        14   34    55    23   0.97   0.46-2.04
  Shi, X H\[[@B22]\]         Jiangsu     2008   34(14-66)     22     19        7    10    25    13   0.46   0.17-1.28
  Wang, Z\[[@B23]\]          Anhui       2001   30.6 ± 16.2   52     54        22   38    64    34   0.62   0.34-1.14
  Xie, Y\[[@B24]\]           Shanghai    2008   4.98 ± 2.78   14     37        6    21    34    7    0.92   0.29-2.93
  Xing, J\[[@B25]\]          Beijing     2001   20-66         9      62        29   29    55    16   2.14   1.08-4.26
  Zhang, X Y\[[@B26]\]       Chongqing   2008   1.08-17       81     111       25   19    23    8    0.68   0.29-1.62
  Wang, J Y\[[@B27]\]        Taiwan      2009   7.82 ± 3.81   138    207       97   173   250   87   1.37   0.99-1.89

###### 

Main data of all studies included in the meta-analysis for the -79G/C (Gln27Glu) polymorphism in *β2-AR*gene

                                                                Case   Control                               
  -------------------------- ----------- ------ --------------- ------ --------- ---- ----- ---- ---- ------ ------------
  Cui, LY(Han)\[[@B17]\]     Neimenggu   2007   21-62           32     6         4    26    3    1    3.05   0.32-28.79
  Gao, G K\[[@B28]\]         Beijing     2002   4-56            20     32        6    32    49   8    1.17   0.38-3.56
  Liao, W\[[@B20]\]          Chongqing   2001   5.8 ± 4.3       26     20        4    20    27   3    1.36   0.29-6.43
  Lin, Y C\[[@B29]\]         Taiwan      2003   13.9 ± 0.07     65     15        0    54    14   1    0.28   0.01-7.08
  Pan, Y P\[[@B30]\]         Jiangxi     2005   \-              15     24        6    17    23   5    1.23   0.35-4.37
  Qiu, Y Y(2000)\[[@B31]\]   Jiangsu     2000   42 ± 5          23     30        6    29    36   7    1.05   0.33-3.32
  Qiu, Y Y(2008)\[[@B21]\]   Jiangsu     2008   63.2 ± 5.6      56     13        1    90    20   2    0.80   0.07-8.96
  Wang, Z\[[@B23]\]          Anhui       2001   30.6 ± 16.2     108    19        1    113   22   1    1.06   0.07-17.18
  Ye, X W\[[@B32]\]          Guizhou     2003   42.68 ± 10.55   25     39        10   15    20   4    1.37   0.40-4.68
  Zhang, X Y\[[@B26]\]       Chongqing   2008   1.08-17         54     119       44   8     24   18   0.45   0.23-0.88

###### 

Main data of all studies included in the meta-analysis for the -1902G/A (Q576R) polymorphism in *IL-4R*gene

                                                             Case   Control                                
  ---------------------- -------------- ------ ------------- ------ --------- ---- ----- ----- ---- ------ -----------
  Cui, T P\[[@B33]\]     Hubei          2003   3-68          129    89        23   130   41    4    2.51   1.64-3.83
  Deng, R Q\[[@B34]\]    Guangdong      2006   8-75          26     42        32   15    38    47   0.50   0.25-1.02
  Gui, Q\[[@B35]\]       Chongqing      2006   49(28-72)     33     15        2    34    14    2    1.09   0.48-2.52
  Hu, S Y\[[@B36]\]      Guangdong      2005   2-16          90     66        19   130   41    4    2.73   1.74-4.28
  Liu, L N\[[@B37]\]     Henan          2005   3-15          46     27        3    47    12    1    2.36   1.09-5.08
  Mak, J C\[[@B38]\]     Hong Kong      2007   42.4 ± 16.1   200    81        4    191   91    9    0.81   0.57-1.15
  Sun, J\[[@B39]\]       Heilongjiang   2010   3-14          67     24        0    33    9     0    1.31   0.55-3.14
  Wu, X H\[[@B40]\]      Hubei          2010   8.8           183    61        8    168   55    4    1.07   0.72-1.61
  Zhang, A M\[[@B41]\]   Hunan          2005   3-14          55     39        0    57    11    0    3.67   1.71-7.89
  Zhang, H\[[@B42]\]     Shanghai       2007   \-            257    87        8    87    27    0    1.19   0.73-1.95
  Zhang, W\[[@B43]\]     Singapore      2007   \-            115    30        0    115   38    4    0.71   0.42-1.22
  Wang, J Y\[[@B27]\]    Taiwan         2009   7.82 ± 3.81   326    112       9    360   140   12   0.88   0.66-1.17

###### 

Main data of all studies included in the meta-analysis for the -223G/A (Ile/Val) polymorphism in *IL-4R*gene

                                                          Case   Control                                  
  ---------------------- ----------- ------ ------------- ------ --------- ----- ----- ----- ----- ------ -----------
  Chan, I H \[[@B16]\]   Hong Kong   2008   10.4 ± 3.7    79     159       57    49    80    38    0.81   0.51-1.29
  Deng, R Q\[[@B44]\]    Guangdong   2006   8-75          24     47        29    9     33    58    0.30   0.16-0.53
  Yang, Q\[[@B45]\]      Jiangxi     2004   18-71         6      21        7     8     16    5     1.24   0.35-4.44
  Zhang, H\[[@B42]\]     Shanghai    2007   \-            106    168       78    44    53    17    1.62   0.92-2.88
  Zhang, W\[[@B43]\]     Singapore   2007   \-            32     84        29    42    76    39    0.76   0.44-1.30
  Wang, J Y\[[@B27]\]    Taiwan      2009   7.82 ± 3.81   105    201       139   124   250   136   1.25   0.94-1.65
  Wu, X H\[[@B40]\]      Hubei       2010   8.8           46     131       75    59    110   58    1.23   0.83-1.85

###### 

Main data of all studies included in the meta-analysis for the -589 C/T polymorphism in *IL-4*gene

                                                          Case   Control                                
  ---------------------- ----------- ------ ------------- ------ --------- ---- ----- ----- ---- ------ -----------
  Cui, T P\[[@B33]\]     Hubei       2003   3-68          141    89        11   114   52    9    1.33   0.89-1.98
  Hu, S Y\[[@B36]\]      Guangdong   2005   2-16          108    59        8    114   52    9    1.16   0.75-1.79
  Liu, L N\[[@B37]\]     Henan       2005   3-15          45     29        2    34    23    3    0.90   0.45-1.79
  Mak, J C\[[@B38]\]     Hong Kong   2007   42.4 ± 16.1   179    95        15   186   87    19   1.08   0.77-1.51
  Wang, W\[[@B46]\]      Xinjiang    2004   39 ± 8        22     42        29   15    26    21   1.03   0.49-2.19
  Wu, X H\[[@B40]\]      Hubei       2010   8.8           163    83        6    132   84    11   0.76   0.52-1.10
  Zhang, W D\[[@B47]\]   Singapore   2005   \-            101    47        4    109   45    3    1.15   0.71-1.85
  Wang, J Y\[[@B27]\]    Taiwan      2009   7.82 ± 3.81   279    145       22   309   183   16   0.93   0.72-1.21

###### 

Main data of all studies included in the meta-analysis for the -308A/G polymorphism in TNF-α gene

                                                           Case   Control                               
  --------------------- ----------- ------ --------------- ------ --------- ---- ----- ---- ---- ------ ------------
  Gao, J M\[[@B48]\]    Beijing     2003   38.7 ± 13.8     47     52        26   44    41   11   1.40   0.82-2.41
  Guo, Y L\[[@B49]\]    Jiangxi     2004   \-              4      28        16   7     11   3    5.50   1.40-21.60
  Li, Z F\[[@B50]\]     Guangdong   2003   2-12            9      16        5    14    10   2    2.72   0.91-8.16
  Liu, R M\[[@B51]\]    Hubei       2004   2-15            98     15        0    104   22   0    0.72   0.36-1.47
  Mak, J C\[[@B38]\]    Hong Kong   2007   42.4 ± 16.1     244    47        1    250   40   2    1.17   0.75-1.84
  Tan, E C\[[@B52]\]    Singapore   1999   \-              49     18        0    115   36   0    1.17   0.61-2.26
  Wang, T N\[[@B53]\]   Taiwan      2004   5-18            140    49        2    111   18   0    2.25   1.24-4.06
  Zhai, F Z\[[@B54]\]   Shandong    2004   35.80 ± 10.18   44     14        6    67    12   1    2.34   1.06-5.19
  Zhao, H J\[[@B55]\]   Jilin       2005   \-              45     5         0    71    9    0    0.88   0.28-2.78
  Wang, J Y\[[@B27]\]   Taiwan      2009   7.82 ± 3.81     345    100       3    409   94   7    1.21   0.89-1.65

###### 

Main data of all studies included in the meta-analysis for the -6843G/A polymorphism in *FcεRI β*gene

                                                            Case   Control                                
  ---------------------- ----------- ------ --------------- ------ --------- ---- ----- ----- ---- ------ ------------
  Chan, I H\[[@B16]\]    Hong Kong   2008   10.4 ± 3.7      267    23        1    154   13    0    1.06   0.53-2.15
  Cui, T P\[[@B56]\]     Hubei       2004   40.37 ± 15.09   60     40        6    78    26    2    2.14   1.20-3.81
  Liu, T\[[@B57]\]       Shandong    2006   36.5            45     14        1    39    10    1    1.18   0.49-2.87
  Tang, Y\[[@B58]\]      Guangdong   2003   39.5(12-67)     49     11        0    61    4     0    3.42   1.03-11.42
  Wang, L\[[@B59]\]      Hubei       2003   2-16            65     40        5    70    20    2    2.20   1.20-4.06
  Zeng, L X\[[@B60]\]    Jiangxi     2001   37(14-63)       61     5         3    27    1     0    3.54   0.42-29.73
  Zhang, X Z\[[@B61]\]   Singapore   2004   52 ± 16         81     57        3    108   42    7    1.63   1.02-2.62
  Zhao, K S\[[@B62]\]    Jilin       2004   1.5-14          126    23        2    92    13    0    1.40   0.68-2.89
  Wang, J Y\[[@B27]\]    Taiwan      2009   7.82 ± 3.81     309    121       16   314   165   27   0.73   0.55-0.95

###### 

Main data of all studies included in the meta-analysis for the -109C/T polymorphism in FcεRI β gene

                                                       Case   Control                              
  ---------------------- ---------- ------ ----------- ------ --------- ---- ---- ---- ---- ------ -----------
  Li, H\[[@B19]\]        Shanghai   2009   3-12        110    58        24   78   90   24   1.00   0.55-1.83
  Wang, L\[[@B59]\]      Hubei      2003   2-16        43     54        13   35   46   11   0.99   0.42-2.32
  Zhao, K S \[[@B63]\]   Jilin      2004   5.6 ± 3.1   46     69        11   40   38   9    0.83   0.33-2.09

###### 

Main data of all studies included in the meta-analysis for the D/I polymorphism in ACE gene

                                                         Case   Control                             
  --------------------- ----------- ------ ------------- ------ --------- ---- ---- ---- --- ------ ------------
  Gao, J M\[[@B64]\]    Beijing     1999   39(16-69)     12     15        23   16   26   8   4.47   1.75-11.43
  Guo, Y B\[[@B65]\]    Guangdong   2006   0.33-3        27     18        7    36   32   4   2.64   0.73-9.56
  Lu, H M\[[@B66]\]     Tianjin     2004   37(18-52)     3      4         11   5    7    3   6.29   1.29-30.54
  Lue, K H\[[@B67]\]    Taiwan      2006   9.91 ± 1.62   48     40        17   56   42   4   4.73   1.53-14.60
  Qin, J H\[[@B68]\]    Liaoning    2000   6.9 ± 2.7     24     10        18   21   14   5   3.71   1.24-11.10
  Song, L J\[[@B69]\]   Jilin       2001   1-14          22     45        41   18   29   9   3.20   1.42-7.20

###### 

Main data of all studies included in the meta-analysis for the -2044A/G polymorphism in IL-13 gene

                                                            Case   Control                                
  --------------------- -------------- ------ ------------- ------ --------- ---- ----- ----- ---- ------ -----------
  Chan, I H\[[@B16]\]   Hong Kong      2008   10.4 ± 3.7    94     136       43   54    70    17   1.18   0.78-1.80
  Feng, D\[[@B70]\]     Heilongjiang   2009   3-16          17     18        10   30    10    3    3.80   1.57-9.23
  Liu, J L\[[@B71]\]    Guangdong      2004   14-67         27     54        19   44    46    10   2.12   1.17-3.84
  Wu, X H\[[@B40]\]     Hubei          2010   8.8           105    111       36   125   84    18   1.72   1.19-2.46
  Yang, L F\[[@B72]\]   Gansu          2010   8 ± 4         71     60        47   73    66    19   1.29   0.84-2.00
  Zhao, K S\[[@B73]\]   Jilin          2005   1.5-14        18     60        52   8     42    50   0.54   0.23-1.30
  Wang, J Y\[[@B27]\]   Taiwan         2009   7.82 ± 3.81   203    194       49   212   234   59   0.87   0.67-1.12
  Xi, D\[[@B74]\]       Hubei          2004   ≥20           15     24        6    23    20    3    2.08   1.28-3.38
  Xi, D\[[@B74]\]       Hubei          2004   ≥4            10     25        8    16    13    2    3.52   1.30-9.55

###### 

Main data of all studies included in the meta-analysis for the -1923C/T polymorphism in IL-13 gene

                                                         Case   Control                                
  --------------------- ----------- ------ ------------- ------ --------- ---- ----- ---- ---- ------- -------------
  Song, Q Z\[[@B75]\]   Guangdong   2005   14-67         24     55        21   43    47   10   2.39    1.06-5.39
  Shi, X H\[[@B22]\]    Jiangsu     2008   34(14-66)     12     26        10   30    16   2    6.05    1.25-29.32
  Chen, J Q\[[@B76]\]   Jiangsu     2004   2.59 ± 1.45   41     43        12   39    14   0    15.83   0.92-272.92
  Wang, X H\[[@B77]\]   Shandong    2009   39 ± 11       31     57        61   66    68   26   3.57    2.10-6.08
  Wu, X H\[[@B40]\]     Hubei       2010   8.8           106    114       32   126   85   16   1.92    1.02-3.60

###### 

Main data of all studies included in the meta-analysis for the -511C/T polymorphism in IL-1β gene

                                                        Case   Control                              
  ---------------------- --------- ------ ------------- ------ --------- ---- ---- ---- ---- ------ -----------
  Hsieh, C C\[[@B78]\]   Taiwan    2004   8.74 ± 4.09   69     93        40   48   70   26   0.96   0.61-1.52
  Wu, Z F\[[@B79]\]      Jiangxi   2007   11-68         16     36        24   26   38   12   1.95   0.94-4.03
  Zhao, X F\[[@B80]\]    Yunnan    2006   5.9(3-14)     51     4         0    30   5    0    0.47   0.12-1.89

###### 

Main data of all studies included in the meta-analysis for the +252A/G polymorphism in LT-α gene

                                                          Case   Control                               
  ---------------------- ----------- ------ ------------- ------ --------- ---- ---- ----- ---- ------ -----------
  Gao, J M\[[@B81]\]     Beijing     2003   38.7 ± 13.8   13     63        49   14   46    36   1.47   0.66-3.30
  Ma, W C\[[@B82]\]      Guangdong   2005   1.8-9         8      14        10   26   46    28   1.05   0.42-2.64
  Mak, J C\[[@B38]\]     Hong Kong   2007   42.4 ± 16.1   70     146       69   79   134   76   1.16   0.80-1.68
  Tan, E C\[[@B52]\]     Singapore   1999   \-            13     38        15   30   84    39   0.99   0.48-2.06
  Xu, X\[[@B83]\]        Guangdong   2003   18-69         12     21        19   26   47    30   1.13   0.51-2.46
  Huang, S C\[[@B84]\]   Taiwan      2008   9.9 ± 4.1     20     69        25   45   69    41   1.62   0.98-2.66

###### 

Main data of all studies included in the meta-analysis for the -509C/T polymorphism in *TGF-β1*gene

                                                        Case   Control                                
  -------------------- ----------- ------ ------------- ------ --------- ---- ---- ----- ----- ------ -----------
  Lu, J R\[[@B85]\]    Jilin       2004   1-13          45     38        15   30   19    3     1.61   0.81-3.17
  Mak, J C\[[@B86]\]   Hong Kong   2006   41.0 ± 16.1   46     109       93   51   155   102   0.87   0.56-1.35
  Xia, W\[[@B87]\]     Jiangxi     2006   15-60         22     26        12   17   11    2     2.26   0.92-5.52

###### 

Main data of all studies included in the meta-analysis for the -159C/T polymorphism in CD14 gene

                                                         Case   Control                                
  --------------------- ----------- ------ ------------- ------ --------- ---- ----- ----- ---- ------ -----------
  Chan, I H\[[@B16]\]   Hong Kong   2008   10.4 ± 3.7    55     134       80   26    77    38   0.88   0.52-1.48
  Chen, M\[[@B88]\]     Guangdong   2009   14-71         63     62        25   40    68    42   0.50   0.31-0.82
  Cui, T P\[[@B89]\]    Hubei       2003   2-16          27     67        49   10    42    20   0.69   0.32-1.52
  Tan, C Y\[[@B90]\]    Taiwan      2006   \-            17     56        47   24    55    41   1.51   0.77-2.99
  Wu, X H\[[@B40]\]     Hubei       2010   8.8           54     117       81   31    121   75   0.58   0.36-0.94
  Wang, J Y\[[@B27]\]   Taiwan      2009   7.82 ± 3.81   160    230       57   177   236   96   0.96   0.73-1.25

###### 

Main data of all studies included in the meta-analysis for the T1-C/T polymorphism in *ADAM33*gene

                                                               Case   Control                              
  ---------------------- -------------- ------ --------------- ------ --------- ---- ----- ---- --- ------ ------------
  Su, D J\[[@B91]\]      Heilongjiang   2008   36.69 ± 11.53   63     78        40   117   29   5   8.28   3.18-21.59
  Wang, P\[[@B92]\]      Shandong       2006   43.32           250    45        1    236   33   1   0.91   0.06-14.65
  Xiong, J Y\[[@B93]\]   Guangdong      2009   6-13            71     19        2    80    10   1   2.00   0.18-22.45

###### 

Main data of all studies included in the meta-analysis for the -28G/C polymorphism in RANTES gene

                                                    Case   Control                            
  --------------------- -------- ------ ----------- ------ --------- --- ---- ---- --- ------ ------------
  Liu, M\[[@B94]\]      Yunnan   2005   7.2 ± 4.8   25     6         1   29   3    0   2.71   0.63-11.59
  Wang, L J\[[@B95]\]   Hubei    2004   9 ± 3       65     31        4   72   17   1   2.15   1.11-4.17
  Yao, T C\[[@B96]\]    Taiwan   2003   \-          134    39        9   83   23   1   1.24   0.71-2.17

###### 

Main data of all studies included in the meta-analysis for the -403A/G polymorphism in RANTES gene

                                                       Case   Control                             
  ---------------------- ---------- ------ ----------- ------ --------- ---- ---- ---- --- ------ -----------
  Leung, T F\[[@B97]\]   Hongkong   2005   9.9 ± 3.4   60     53        16   37   21   8   1.47   0.81-2.66
  Liu, M\[[@B94]\]       Yunnan     2005   7.2 ± 4.8   17     13        2    16   14   2   0.88   0.33-2.35
  Yao, T C\[[@B96]\]     Taiwan     2003   \-          98     65        19   60   41   6   1.09   0.68-1.77

Summary results of Meta-analyzes
--------------------------------

For each polymorphism, heterogeneity was analyzed by a *X^2^*-based *Q*statistic and was considered statistical significant at *P*-value \<0.10. When the *P*-value is less than 0.10, the pooled OR of each meta-analysis was calculated by the fixed-effects model; otherwise, a random-effects model was used. The chosen models to synthesize the data for each polymorphism can be seen in Table [20](#T20){ref-type="table"}.

###### 

Summary results of the meta-analysis and publications bias

                                                                Pubilication bias (Begg\'s test)   
  -------- ---------- ------- ---- -------- ------------------- ---------------------------------- -------
  β2-AR    -46G/A     GG      13   Random   1.02(0.75, 1.38)    -0.66                              0.525
           -79G/C     GG      10   Fixed    0.86(0.58, 1.29)    1.60                               0.148
  IL-4R    -1902G/A   GG+GA   12   Random   1.30(0.94, 1.80)    0.92                               0.377
           -223G/A    GG      7    Random   0.92(0.63, 1.35)    -0.81                              0.453
  IL-4     -589C/T    CC+CT   8    Fixed    1.01(0.88, 1.16)    0.53                               0.615
  TNF-α    -308A/G    AA+AG   10   Random   1.42(1.09, 1.85)    1.38                               0.205
  FcεRIβ   -6843G/A   GG+GA   9    Random   1.49(1.01, 2.22)    2.82                               0.026
           -109C/T    CC      3    Fixed    0.96(0.62, 1.48)    -1.10                              0.471
  ACE      D/I        DD      6    Fixed    3.85(2.49, 5.94)    0.88                               0.429
  IL-13    -2044A/G   AA+AG   9    Random   1.49(1.07, 2.08)    1.93                               0.095
           -1923C/T   TT      5    Fixed    2.99(2.12, 4.24)    1.19                               0.320
  IL-1β    -511C/T    TT+TC   3    Fixed    1.10(0.76, 1.59\_   -0.16                              0.896
  LT-α     +252A/G    GG+GA   6    Fixed    1.26(0.98, 1.62)    -0.02                              0.985
  TGF-β1   -509C/T    TT+TC   3    Fixed    1.17(0.83, 1.64)    8.57                               0.074
  CD14     -159C/T    TT+TC   6    Random   0.79(0.59, 1.06)    -0.41                              0.700
  ADAM33   T1-C/T     CC      3    Fixed    6.07(2.69, 13.73)   -8.22                              0.077
  RANTES   -28G/C     GG+GC   3    Fixed    1.64(1.09, 2.46)    0.87                               0.544
           -403A/G    AA+AG   3    Fixed    1.18(0.83, 1.67)    -0.37                              0.777

Forest plots of each polymorphism can be seen in Figure [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}, [8](#F8){ref-type="fig"}, [9](#F9){ref-type="fig"}, [10](#F10){ref-type="fig"}, [11](#F11){ref-type="fig"}, [12](#F12){ref-type="fig"}, [13](#F13){ref-type="fig"}, [14](#F14){ref-type="fig"}, [15](#F15){ref-type="fig"}, [16](#F16){ref-type="fig"}, [17](#F17){ref-type="fig"}, [18](#F18){ref-type="fig"} and [19](#F19){ref-type="fig"}. In summary, we abstained significant results for seven polymorphisms: *ADAM33*T1-C/T (OR = 6.07, 95%CI: 2.69-13.73, *Z*= 4.33, *P*\< 0.0001), *ACE*D/I(OR = 3.85, 95%CI: 2.49-5.94, *Z*= 6.07, *P*\< 0.00001), *FcεRIβ*-6843G/A (OR = 1.49, 95%CI: 1.01-2.22, *Z*= 1.99, *P*= 0.05), *IL-13*-1923C/T(OR = 2.99, 95%CI: 2.12-4.24, *Z*= 6.19, *P*\< 0.00001), *IL-13*-2044A/G(OR = 1.49, 95%CI: 1.07-2.08, *Z*= 2.34, *P*= 0.02), *RANTES*-28C/G (OR = 1.64, 95%CI: 1.09-2.46, *Z*= 2.36, *P*= 0.02), *TNF-α*-308G/A (OR = 1.42, 95%CI: 1.09-1.85, *Z*= 2.63, *P*= 0.009). These results indicated that these polymorphisms were significant associated with asthma risk in Chinese population. All results for all 18 meta-analyzes are summarized in table [20](#T20){ref-type="table"}.

![**Forest plot of asthma risk associated with *β2-AR*-46G/A in Chinese population**. Subgroup analysis by age.](1465-9921-11-129-2){#F2}

![**Forest plot of asthma risk associated with *β2-AR*-79G/C in Chinese population**. Subgroup analysis by age.](1465-9921-11-129-3){#F3}
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![**Forest plot of asthma risk associated with *IL-4*-589C/T in Chinese population**. Subgroup analysis by age.](1465-9921-11-129-6){#F6}

![**Forest plot of asthma risk associated with *TNF-α*-308A/G in Chinese population**. Subgroup analysis by age.](1465-9921-11-129-7){#F7}

![**Forest plot of asthma risk associated with *FcεRIβ*-6843G/A in Chinese population**. Subgroup analysis by age.](1465-9921-11-129-8){#F8}

![**Forest plot of asthma risk associated with *FcεRIβ*-109C/T in Chinese population**.](1465-9921-11-129-9){#F9}

![**Forest plot of asthma risk associated with *ACE*D/I in Chinese population**. Subgroup analysis by age.](1465-9921-11-129-10){#F10}

![**Forest plot of asthma risk associated with *IL-13*-2044A/G in Chinese population**. Subgroup analysis by age.](1465-9921-11-129-11){#F11}

![**Forest plot of asthma risk associated with *IL-13*-1923C/T in Chinese population**.](1465-9921-11-129-12){#F12}

![**Forest plot of asthma risk associated with *IL-1β*-511C/T in Chinese population**.](1465-9921-11-129-13){#F13}
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![**Forest plot of asthma risk associated with *TGF-β1*-509C/T in Chinese population**.](1465-9921-11-129-15){#F15}

![**Forest plot of asthma risk associated with *CD14*-159C/T in Chinese population**.](1465-9921-11-129-16){#F16}

![**Forest plot of asthma risk associated with *ADAM33*T1-C/T in Chinese population**.](1465-9921-11-129-17){#F17}

![**Forest plot of asthma risk associated with *RANTES*-28G/C in Chinese population**.](1465-9921-11-129-18){#F18}

![**Forest plot of asthma risk associated with *RANTES*-403A/G in Chinese population**.](1465-9921-11-129-19){#F19}

To evaluate the age-specific effects, subgroup analyses were performed by age for polymorphisms which were investigated in a sufficient number of studies(data were available from at least three case-control studies for at least one subgroup). Three subgroups were used: adults, children, others(ages in these case-control studies were not mentioned or mixed with adults and children). Briefly, we obtained significant results from five polymorphisms(*ACE*D/I, *β2-AR*-79G/C, *TNF-α*-308G/A, *IL-4R*-1902G/A and *IL-13*-1923C/T) in children and five polymorphisms(*ACE*D/I, *FcεRIβ*-6843G/A, *TNF-α*-308G/A, *IL-13*-1923C/T, *IL-13*-2044A/G) in adults.

Publication bias
----------------

The Begg\'s funnel plots and Egger\'s tests were performed to assess the potential publication bias (Begg\'s funnel plots can be seen in Additional File [1)](#S1){ref-type="supplementary-material"}. The results did not suggest evidence of publication bias except for the *FcεRIβ*-6843G/A polymorphism. Statistical results of Begg\'s test are summarized in Table [20](#T20){ref-type="table"}.

Discussion
==========

The aim of meta-analysis is to combine results from studies on the same topic and to produce more precise results. The current study is to reveal the roles of genetic variants and their associations with risk of asthma in Chinese population. In summary, we finally identified 18 polymorphisms in 13 genes. Among them, seven polymorphisms (*ADAM33*T1-C/T, *ACE*D/I, *FcεRIβ*-6843G/A, *IL-13*-1923C/T, *IL-13*-2044A/G, *RANTES*-28C/G and *TNF-α*-308G/A) were statistically associated with increased risk of asthma. In order to analysis the age-specific associations, subgroup analysis were performed by age. The *ACE*D/I, *β2-AR*-79G/C, *TNF-α*-308G/A, *IL-4R*-1902G/A and *IL-13*-1923C/T polymorphisms were found being associated with asthma risk in Chinese children, while the *ACE*D/I, *FcεRIβ*-6843G/A, *TNF-α*-308G/A, *IL-13*-1923C/T, *IL-13*-2044A/G polymorphisms were associated with asthma risk in Chinese adults. Given that the data for each polymorphism were from at least three case-control studies, the obtained results could be more precise than results obtained form any individual study.

The *β2-AR*gene is a critical gene in the pathogenesis of asthma. β2-ARs are present on many airway cells, especially in smooth muscle cells which are hyperreactive in asthmatic patients. At present, β2-AR agonists were major methods for treating asthmatic patients. In this meta-analysis, ten case-control studies for *β2-AR*-79G/C and eleven for -46G/A polymorphism were identified. The results indicated the two polymorphisms were not associated with asthma risk in Chinese population. After subgroup analysis by age, the -79G/C polymorphism was associated with decreased risk of asthma in Chinese children. Up to now, three meta-analyses had been performed to investigate the association between polymorphism of *β2-AR*gene and risk of asthma \[[@B10]-[@B12]\]. Thakkinstian A\[[@B12]\] found that the heterozygote in -79G/C was associated with decreased risk of asthma in both adults and children. However, we didn\'t find these associations in Chinese adults, which suggested different roles of this polymorphism may exist in the pathogenesis of asthma in difference age groups. Previous study indicated that the -46G allele enhanced agonist-induced down regulation of the receptor, and the -79G allele might enhance resistance to down regulation. In combination with our results, personalized therapy of asthma patients in different age population with different genetic backgrounds in Chinese population should also be carried out in clinical practices.

The TNF-α gene, encodes a key proinflammatory cytokine in airway, is located on an asthma susceptible region-chromosome 6p. The TNF-α protein plays a central role in inflammation and involves in pathogenesis of asthma. Several polymorphisms have been identified in this gene, such as -308A/G, -238A/G. The -308A/G polymorphism in the promoter may affect the expression of this cytokine, which may affect the occurrence of asthma. In the meta-analysis performed by Gao and colleagues\[[@B13]\], they found the A allele was significant with increased risk of asthma (OR = 1.37, 95%CI = 1.02-1.84 for A vs. G). Consistently, we found the *TNF-α*-308A/G polymorphism was significantly associated with increased risk of asthma (OR = 1.36, 95%CT = 1.13-1.63 for AA+AG vs. GG) in Chinese population. For A vs G, the pooled OR is 1.26 with 95%CI: 1.08-1.47 in this study, which suggested a weaker association between this polymorphism and asthma risk in Chinese population.

*IL-4*gene is located on chromosome 5q31, it was suggested to be associated with asthma risk, including elevated serum IgE levels and airway hypersensitiveness. A few studies indicated the -589C/T polymorphism in the promoter as a risk factor for asthma, but with inconclusive results. Li and colleagues performed a meta-analysis and found the T allele was associated with decrease risk of asthma(T vs C: OR = 0.86, 95%CI = 0.78-0.94)\[[@B14]\]. However, our results didn\'t reveal a positive association between this polymorphism and risk of asthma in Chinese. Compared with Li\'s study, the total number of studies concerning the Chinese population was smaller, which suggested more studies should be carried out to reveal these associations.

IL-4 and IL-13 signal through binding to a receptor complex comprised of the IL-13Rα1 and IL-4Rα with subsequent phosphorylation of JAKs and STAT6\[[@B15]\]. IL-4 receptor plays its role in inflammation through IL-4 and IL-13. The *IL-4 receptor*gene is located on chromosome 16 p12.1-p11.2. Some polymorphisms had been identified as risk factors for asthma, such as -1902G/A and -223G/A. Our results indicated the -1902G/A polymorphism was associated with increased risk of asthma in Chinese children, but not in Chinese adults. The results also indicated the -223G/A polymorphism was not associated with risk of asthma in Chinese population.

The *FcεRIβ*gene is a major candidate gene, involving in the pathogenesis of asthma. It is located on the chromosome 11q13. The -6843G/A polymorphism, leading change in an amino acid sequence at residue 237 from glutamic acid to glycine, is associated with increased IgE levels in atopic asthmatic children. In Chinese population, the -6843G/A polymorphism is the most extensively studied polymorphism in *FcεRIβ*gene. Our study revealed this polymorphism as a risk factor of asthma in Chinese population. Chinese who carry the GG or GA genotype have an 49% increased risk of asthma than AA carriers. Our results also demonstrated the -109C/T polymorphism in this gene was not associated with increased risk of asthma in Chinese population.

Up to date, we first found that *ADAM33*T1-C/T, *ACE*D/I, *IL-13*-1923C/T, *RANTES*-28C/G and *IL-13*-2044A/G polymorphisms were associated with risk of asthma in Chinese population by using meta-analyzes. Some results are similar to other studies performed in other ethnic- groups and some are not. In future, more published results should be included to update and validate these associations in Chinese population.

In this study, the rigorous inclusive criteria made the results more precise. Any study in which genotype distribution of control group divorced from HWE was excluded. In this meta-analysis, 11 polymorphisms were synthesized by using the fixed-effect model, 7 used random-effects model. Because the fixed-effect model is more precise than random effect model, the strength of evidence of *ADAM33*T1-C/T, *ACE*D/I, *IL-13*-1923C/T, *RANTES*-28C/G, as risk factors for asthma was greater than that of *FcεRIβ*-6843G/A, *IL-13*-2044A/G and *TNF-α*-308G/A.

The heterogeneity of clinical information among studies should also be mentioned. Heterogeneity is an important issue when interpreting the results of meta-analysis. Significant heterogeneity existed in overall comparisons in a few meta-analyses, such as *FcεRIβ*-6843G/A. After subgroup analyses by age, the heterogeneity was effectively decreased or removed in adults. Possible explanation may be that differences in etiology may exist in difference age groups. Another important factor contributing to heterogeneity was that homogeneity in either the case and control groups was uncertain. Ideally, all cases and controls in this meta-analysis should be matched for age, sex, atopic status and environmental exposures. However, these issues could not all be explained precisely because of insufficient clinical information for individual person. In addition, because this study is based on population of Chinese descent with the same genetic background, so the similarity of these studies might be very good, despite most studies were conducted in different areas of China.

Some limitations of this meta-analysis should be acknowledged when explaining our results. First, only published articles in the selected electronic databases were included in this study, it may be possible that some studies were not included in those databases or some unpublished studies which had null results, which might bias the results. Second, due to lack of sufficient data, the homogeneity in either the case and control groups was uncertain and data were not stratified by other factors such as atopic status or sex. The tests for gene-environment interactions were not carried out either. Third, publication bias may affect the results. Although *P*values of Begg\'s test were more than 0.05 in 18 meta-analyses, we could not rule out this possibility, because for some polymorphisms, the included number of studies were relatively small. Third, this study didn\'t included some polymorphisms with lack of number of studies, or polymorphisms which were not characterized as -A/B for lack of quality analysis for HWE, some polymorphism, such as GSTM1-P/N, or HLA DR1 alleles and MHC alleles were not included, future studies should performed to analysis the effect of these polymorphism in Chinese population.

To our knowledge, this is the first and most comprehensive genetic meta-analysis to date conducted in Chinese descent for any respiratory diseases. In conclusion, this meta-analysis indicated the T1-C/T polymorphism in *ADAM33*gene, the D/I polymorphism in *ACE*gene, the -6843G/A polymorphism in *FcεRIβ*gene, the -1923C/T polymorphism in *IL-13*gene, the -2044A/G polymorphism in *IL-13*gene, the -28C/G polymorphism in *RANTES*gene and the -308G/A polymorphism in *TNF-α*gene are associated with asthma risk in Chinese population. And these results may also implicate in personalized therapy for asthma in Chinese population. In future, more studies should be conducted to investigate the gene-gene and gene-environment interactions between these polymorphisms in Chinese population.
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